Scott Gottlieb

Scott Gottlieb is a General Partner at New Enterprise Associates and Board Chair at Tempus AI, based in New York City. He previously served as the Commissioner of the Food and Drug Administration from 2017 to 2019, following an earlier tenure as the agency's Deputy Commissioner between 2005 and 2007. Alongside his venture capital work, he holds corporate governance roles across the life sciences sector, including serving on the board of directors at Pfizer. A physician by training, he completed his medical degree and internal medicine residency at the Mount Sinai School of Medicine after earning an economics degree from Wesleyan University. He authored the 2021 book "Uncontrolled Spread" and maintains a public health platform with over 500,000 followers. His current focus centers on advancing biotechnology investments, guiding healthcare policy, and supporting medical technology innovation.